Filing Details
- Accession Number:
- 0001288123-11-000096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-29 16:08:57
- Reporting Period:
- 2011-12-27
- Filing Date:
- 2011-12-29
- Accepted Time:
- 2011-12-29 16:08:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1098972 | Agenus Inc | AGEN | Biological Products, (No Disgnostic Substances) (2836) | 061562417 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1377202 | Shalini Sharp | C/O Antigenics Inc. 162 Fifth Ave., Suite 900 New York NY 10010 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-12-27 | 2,853 | $2.14 | 43,355 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-12-28 | 1,711 | $2.09 | 41,644 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the sale of shares sold to cover anticipated Federal, state and local tax withholding requirements on future stock award.
Billionaire Hedge Funds
